| Literature DB >> 32318565 |
Dongbo Cai1, Bowen Zhang1, Jiang Zhu1, Haixia Xu1, Pei Liu1, Zhi Wang2, Junhui Li3, Zhifan Yang1, Xin Ma1, Shouwen Chen1.
Abstract
Bacitracin is a broad-spectrum veterinary antibiotic that widely used in the fields of veterinary drug and feed additive. S-Adenosylmethionine (SAM) is a critical factor involved in many biochemical reactions, especially antibiotic production. However, whether SAM affects bacitracin synthesis is still unknown. Here, we want to analyze the relationship between SAM supply and bacitracin synthesis, and then metabolic engineering of SAM synthetic pathway for bacitracin production in Bacillus licheniformis. Firstly, our results implied that SAM exogenous addition benefited bacitracin production, which yield was increased by 12.13% under the condition of 40 mg/L SAM addition. Then, SAM synthetases and Methionine (Met) synthetases from B. licheniformis, Corynebacterium glutamicum, and Saccharomyces cerevisiae were screened and overexpressed to improve SAM accumulation, and the combination of SAM synthetase from S. cerevisiae and Met synthetase from B. licheniformis showed the best performance, and 70.12% increase of intracellular SAM concentration (31.54 mg/L) and 13.08% increase of bacitraicn yield (839.54 U/mL) were achieved in resultant strain DW2-KE. Furthermore, Met transporters MetN and MetP were, respectively, identified as Met exporter and importer, and bacitracin yield was further increased by 5.94% to 889.42 U/mL via deleting metN and overexpressing metP in DW2-KE, attaining strain DW2-KENP. Finally, SAM nucleosidase gene mtnN and SAM decarboxylase gene speD were deleted to block SAM degradation pathways, and bacitracin yield of resultant strain DW2-KENPND reached 957.53 U/mL, increased by 28.97% compared to DW2. Collectively, this study demonstrated that SAM supply served as the critical role in bacitracin synthesis, and a promising strain B. licheniformis DW2-KENPND was attained for industrial production of bacitracin.Entities:
Keywords: Bacillus licheniformis; S-Adenosylmethionine; bacitracin; metabolic engineering; methionine
Year: 2020 PMID: 32318565 PMCID: PMC7155746 DOI: 10.3389/fbioe.2020.00305
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
The strains and plasmids used in this research.
| Strains and plasmids | Relevant properties | Source of references |
| This study | ||
| Wide-type CCTCC M2011344 | CCTCC | |
| DW2/pHY-metKBl | DW2 harboring SAM synthetase MetK expression vector pHY-metKBl | This study |
| DW2/pHY-metKCg | DW2 harboring SAM synthetase MetKCg expression vector pHY-metKCg | This study |
| DW2/pHY-SAM2 | DW2 harboring SAM synthetase SAM2 expression vector pHY-SAM2 | This study |
| DW2/pHY-300 | DW2 harboring pHY300PLK, as the control strain | This study |
| DW2-K | SAM synthetase SAM2 integrated overexpression strain, based on strain DW2 | This study |
| DW2-K/pHY-metHBl | DW2-K harboring Met synthetase MetH expression vector pHY-metHBl | This study |
| DW2-K/pHY-metHCg | DW2-K harboring Met synthetase MetH expression vector pHY-metHCg | This study |
| DW2-K/pHY-Met6 | DW2-K harboring Met synthetase Met6 expression vector pHY-Met6 | This study |
| DW2-KE | Met synthetase MetH overexpression strain via promoter replacement, based on strain DW2-K | This study |
| DW2/pHY-metN | DW2 harboring Met transporter MetN expression vector pHY-metN | This study |
| DW2/pHY-metP | DW2 harboring Met transporter MetP expression vector pHY-metP | This study |
| DW2△metN | Deletion of | This study |
| DW2△metP | Deletion of | This study |
| DW2-KEN | Deletion of | This study |
| DW2-KENP | Overexpression of | This study |
| DW2-KENP△mtnN | Deletion of | This study |
| DW2-KENP△speD | Deletion of | This study |
| DW2-KENPND | Deletion of | This study |
| pHY300PLK | Lab collection | |
| T2(2)-Ori | Lab collection | |
| pHY-metKBl | SAM synthetase MetKBl expression vector, based on pHY300PLK | This study |
| pHY-metKCg | SAM synthetase MetKCg expression vector, based on pHY300PLK | This study |
| pHY-SAM2 | SAM synthetase SAM2 expression vector, based on pHY300PLK | This study |
| pHY-MetHBl | Met synthetase MetHBl expression vector, based on pHY300PLK | This study |
| pHY-metHCg | Met synthetase MetHCg expression vector, based on pHY300PLK | This study |
| pHY-Met6 | Met synthetase Met6 expression vector, based on pHY300PLK | This study |
| pHY-metN | Met transporter MetN expression vector, based on pHY300PLK | This study |
| pHY-metP | Met transporter MetP expression vector, based on pHY300PLK | This study |
| T2-:SAM2 | T2(2)-Ori- | This study |
| T2-PbacA-PmetH | T2(2)-Ori- | This study |
| T2-metN | T2(2)-Ori- | This study |
| T2-metP | T2(2)-Ori- | This study |
| T2-PbacA-PmetP | T2(2)-Ori- | This study |
| T2-mtnN | T2(2)-Ori- | This study |
| T2-speD | T2(2)-Ori- | This study |
FIGURE 1Effects of exogenous SAM addition on bacitracin production. (A) Effects of different concentrations of SAM (20, 30, 40, 50, and 60 mg/L) additions on bacitracin yield, (B) Effects of SAM addition on the transcriptional levels of bacitracin synthetase genes bacT, bacA, bacB, and bacC. ∗P < 0.05 and ∗∗P < 0.01 indicate the significance levels between recombinant strains and control strain.
FIGURE 2Metabolic engineering of SAM synthetic and degradation, Met transportation pathways for SAM accumulation and bacitracin synthesis in B. licheniformis.
FIGURE 3Effects of strengthening SAM synthetase expression on SAM accumulation and bacitracin production. (A) Effects of SAM synthetase overexpression on bacitracin yield and cell biomass, (B) Effects of integrated overexpression of SAM2 from S. cerevisiae on bacitraicn yield, cell biomass and SAM accumulation, (C) Effects of SAM2 overexpression on the transcriptional levels of bacitracin synthetase genes bacT, bacA, bacB, and bacC. ∗P < 0.05 and ∗∗P < 0.01 indicate the significance levels between recombinant strains and control strain.
FIGURE 4Effects of methionine synthetase overexpression on bacitracin production and cell biomass. (A) Bacitracin yield and cell biomass, (B) The concentrations of intracellular SAM and Met. ∗P < 0.05 and ∗∗P < 0.01 indicate the significance levels between recombinant strains and control strain.
FIGURE 5Identifying and engineering Met transporters for enhancement production of bacitracin. (A) The extracellular and intracellular of Met in ME medium, (B) Effects of deletion and overexpression of metN and metP on bacitracin production and cell biomass, (C) The concentrations of intracellular Met and SAM, (D) The concentrations of extracellular Met and SAM, (E) Effects of metN deletion and metP overexpression on bacitracin yields and intracellular SAM concentrations. ∗P < 0.05 and ∗∗P < 0.01 indicate the significance levels between recombinant strains and control strain.
FIGURE 6Effects of mtnN and speD deletion on bacitraicn production. (A) Bacitracin yield and cell biomass, (B) The concentration of intracellular SAM, (C) The concentrations of cadaverine and putrescine, (D) Transcriptional level analysis. ∗P < 0.05 and ∗∗P < 0.01 indicate the significance levels between recombinant strains and control strain.
FIGURE 7The fermentation process curves of B. licheniformis DW2 and DW2-KENPND.